GLP-1 receptor agonist use linked to chronic cough among adults with type 2 diabetesGLP-1 receptor agonist use linked to chronic cough among adults with type 2 diabetes
For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online Nov. 26 in JAMA Otolaryngology-Head & Neck Surgery. For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic Read More
Biomarkers link ER+ breast cancer to neighborhood povertyBiomarkers link ER+ breast cancer to neighborhood poverty
Scientists have long known that Black women with estrogen-receptor positive breast cancer and those who live in disadvantaged neighborhoods often have more aggressive forms of the disease and poorer survival rates. However, the underlying factors that link these outcomes with women’s living environments have remained unclear.
Alcohol Use, Lifestyle Factors Shape Breast Cancer RiskAlcohol Use, Lifestyle Factors Shape Breast Cancer Risk
(MedPage Today) — In this exclusive video ahead of the upcoming San Antonio Breast Cancer Symposium (SABCS), Seema Kahn, MD, of Northwestern University Feinberg School of Medicine in Chicago, previews her session on alcohol use, metabolism, and…
Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setbackNovo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback
Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing trials last month. Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing trials last month.
“Paw-zempic”: Could GLP-1 drugs work for obese cats?”Paw-zempic”: Could GLP-1 drugs work for obese cats?
Weight loss drugs for Americans have skyrocketed to success. Now, the GLP-1 frenzy could be heading to a new frontier: your pets. A San Francisco biopharmaceutical company says it is conducting a pilot study on a GLP-1 drug for cats with obesity. Okava CEO Michael Klotsman joins CBS News to discuss. Weight loss drugs for Read More
Spatial Omics May Transform the Future of Breast Cancer TreatmentSpatial Omics May Transform the Future of Breast Cancer Treatment
(MedPage Today) — In this exclusive video ahead of the upcoming San Antonio Breast Cancer Symposium (SABCS), Leif W. Ellisen, MD, PhD, of Harvard Medical School and Massachusetts General Hospital in Boston, previews his session on advances in…
Promoting Awareness of Inflammatory Breast CancerPromoting Awareness of Inflammatory Breast Cancer
(MedPage Today) — Despite recent progress in understanding the disease, inflammatory breast cancer (IBC) remains a challenge to diagnose and treat, and the prognosis remains worse than for breast cancer in general.
IBC accounts for 2% to 4% of…
Supplemental Breast Cancer Screening in Women With Dense BreastsSupplemental Breast Cancer Screening in Women With Dense Breasts
(MedPage Today) — In 2023, the FDA updated its mammography regulations, with a key amendment that required facilities to provide information to patients regarding the density of their breasts.
This amendment featured specific language explaining…
Ozempic Improves Glycemic Control, Cuts Weight in Schizophrenia PatientsOzempic Improves Glycemic Control, Cuts Weight in Schizophrenia Patients
(MedPage Today) — Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose schizophrenia was being treated with the second-generation antipsychotics clozapine or olanzapine. The… (MedPage Today) — Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose schizophrenia was Read More
Breast cancer remodels lymphatic vessels to accelerate its spread, research revealsBreast cancer remodels lymphatic vessels to accelerate its spread, research reveals
Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes. From there, it can then spread to other parts of the body. A new finding by Finnish researchers may help develop targeted therapies that could prevent this spread.